Patrik Fridh

ORCID: 0000-0002-5046-7499
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Transportation Planning and Optimization
  • Immune cells in cancer
  • Urban and Freight Transport Logistics

Science for Life Laboratory
2023

Uppsala University
2023

Inflammatory mediators released by cancer cells promote the induction of immune suppression and tolerance in myeloid cells. IL-1 receptor–associated kinase-3 (IRAK3) is a pseudokinase that inhibits IL-1/TLR signaling, but its role patients treated with checkpoint blockade (ICB) therapy remains unclear. Using RNA-Seq data from IMvigor210 trial, we found tumors high IRAK3 expressions showed enriched antiinflammatory pathways worse clinical response to ICB therapy. Upon protein deletion...

10.1172/jci161084 article EN cc-by Journal of Clinical Investigation 2023-02-09
Coming Soon ...